Loading…
Calcofluor white-cholesteryl hydrogen succinate conjugate mediated liposomes for enhanced targeted delivery of voriconazole into Candida albicans
Fungal infections gradually lead to a high mortality rate due to difficulties in diagnosis, the limited number of antifungal drugs available, and the appearance of resistant isolates. Here, we developed a calcofluor white-cholesteryl hydrogen succinate conjugate (CFW-CHSc) as a novel nanomaterial th...
Saved in:
Published in: | Biomaterials science 2022-12, Vol.11 (1), p.307-321 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Fungal infections gradually lead to a high mortality rate due to difficulties in diagnosis, the limited number of antifungal drugs available, and the appearance of resistant isolates. Here, we developed a calcofluor white-cholesteryl hydrogen succinate conjugate (CFW-CHSc) as a novel nanomaterial that specifically binds to chitin chains in the cell wall. We showed that fluorescent-dye loaded CFW-CHSc-liposomes entered the cytoplasm of
cells with increased efficacy. Voriconazole-loaded CFW-CHSc-liposomes displayed an increased antifungal activity against
yeast cells in an
assay. Animal infection models and animal imaging analysis showed that fluorescent-dye loaded CFW-CHSc-liposomes maintained prolonged residence in rodent tissues. In mouse liver and kidney tissue, voriconazole-loaded CFW-CHSc-liposomes showed significantly enhanced antifungal activity when administered intravenously. Taken together, our studies confirm that CFW-CHSc increases the drug delivery efficacy of nanoparticles
by interacting with chitin chains in the
cell wall. The fungi-targeting nanoparticles improve the drug delivery efficacy
by enriching the nanoparticles at the site of fungal infection
the blood circulation system. Fungi-targeting nanomaterials have a promising future in the treatment of nosomycosis. |
---|---|
ISSN: | 2047-4830 2047-4849 |
DOI: | 10.1039/d2bm01263d |